Older articles »
|Computer program finds new uses for old drugs|
Added: 17.11.2017 0:18 | 21 views | 0 comments
Researchers have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy. In a recent study, the researchers successfully translated DrugPredict results into the laboratory, and showed common pain medications -- like aspirin -- can kill patient-derived epithelial ovarian cancer cells.
|FDA OKs new therapy for some hemophilia patients|
Added: 16.11.2017 23:40 | 3 views | 0 comments
U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.
|Botulinum toxin injections may provide relief for children and teens with hard-to-treat migraines|
Added: 16.11.2017 15:40 | 2 views | 0 comments
One in 10 school-aged children suffer from migraines, but there are few FDA-approved medications for them. While botulinum toxin injections are approved to treat migraines in adults, children and teens may benefit as well, early research suggests.
|FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis|
Added: 16.11.2017 2:10 | 1 views | 0 comments
The U.S. Food and Drug Administration has cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in...
|Rapamycin treatment prevents crippling abnormal bone formation after severe limb injuries|
Added: 15.11.2017 2:12 | 3 views | 0 comments
Individuals with severe injuries to their extremities often develop abnormal extra-skeletal bone in damaged or healing tissue, known as heterotopic ossification (HO). This post-traumatic abnormal wound healing can interfere with recovery, causing chronic pain, reduced mobility, and impaired prosthetic limb function. Rapamycin, an FDA-approved drug already on the market, was found to dramatically reduce the presence of HO in rats, suggesting it has potential to become the first effective treatment to prevent HO.
|FDA approves first generic Strattera for the treatment of ADHD|
Added: 15.11.2017 2:11 | 4 views | 0 comments
The U.S. Food and Drug Administration has approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
|FDA Cracks Down on Kratom, Angering Fans|
Added: 14.11.2017 23:09 | 6 views | 0 comments
Kratom can kill you and doesn't belong on the market, the FDA says.
Copyright © 2008-2017 USweekly - all rights reserved